Alessa Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$25.4M
- Investors
-
10
Alessa Therapeutics General Information
Description
Developer of a drug delivery implantable system designed to treat patients with prostate cancer. The company's system helps to administer anti-androgen drugs to the tumor in the prostate through a sustained and localized system without systemic exposure, enabling patients to have localized treatments for solid organ disease.
Contact Information
Website
www.alessatherapeutics.comCorporate Office
- 930 Brittan Avenue
- San Carlos, CA 94070
- United States
Corporate Office
- 930 Brittan Avenue
- San Carlos, CA 94070
- United States
Alessa Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A) | 18-Apr-2025 | $25.4M | Completed | Clinical Trials - Phase 1 | ||
| 6. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 5. Accelerator/Incubator | 07-Oct-2022 | Completed | Clinical Trials - Phase 1 | |||
| 4. Grant | 04-Aug-2021 | Completed | Clinical Trials - Phase 1 | |||
| 3. Seed Round | 02-Jan-2020 | Completed | Clinical Trials - Phase 1 | |||
| 2. Seed Round | 21-Mar-2019 | $3M | $3M | Completed | Clinical Trials - Phase 1 | |
| 1. Accelerator/Incubator | Completed | Startup |
Alessa Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 5,392,075 | $0.000010 | 6% | $0.65 | $0.65 | 1x | $0.55 | 6.26% |
| Seed | 7,718,968 | $0.000010 | 6% | $0.43 | $0.43 | 1x | $0.43 | 7.57% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Alessa Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alessa Therapeutics Patents
Alessa Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026136857-A1 | Drug implants containing parp inhibitors and methods of use thereof | Pending | 20-Dec-2024 | ||
| AU-2024405203-A1 | Drug implants containing talazoparib and methods of use thereof | Pending | 19-Dec-2023 | ||
| EP-4808548-A1 | Drug implants containing talazoparib and methods of use thereof | Pending | 19-Dec-2023 | ||
| WO-2025137096-A1 | Drug implants containing talazoparib and methods of use thereof | Inactive | 19-Dec-2023 | ||
| AU-2023308934-A1 | Drug implants containing darolutamide and methods of use thereof | Pending | 20-Jul-2022 | A61K31/4155 |
Alessa Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Alessa Therapeutics Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cure Ventures | Venture Capital | Minority | ||
| UCI Beall Applied Innovation | Accelerator/Incubator | |||
| National Institutes of Health | Government | |||
| iO life ventures | Corporate Venture Capital | Minority | ||
| Johnson & Johnson | Corporation | Minority |
Alessa Therapeutics FAQs
-
When was Alessa Therapeutics founded?
Alessa Therapeutics was founded in 2018.
-
Where is Alessa Therapeutics headquartered?
Alessa Therapeutics is headquartered in San Carlos, CA.
-
What is the size of Alessa Therapeutics?
Alessa Therapeutics has 13 total employees.
-
What industry is Alessa Therapeutics in?
Alessa Therapeutics’s primary industry is Drug Delivery.
-
Is Alessa Therapeutics a private or public company?
Alessa Therapeutics is a Private company.
-
What is the current valuation of Alessa Therapeutics?
The current valuation of Alessa Therapeutics is .
-
What is Alessa Therapeutics’s current revenue?
The current revenue for Alessa Therapeutics is .
-
How much funding has Alessa Therapeutics raised over time?
Alessa Therapeutics has raised $31.6M.
-
Who are Alessa Therapeutics’s investors?
Cure Ventures, UCI Beall Applied Innovation, National Institutes of Health, iO life ventures, and Johnson & Johnson are 5 of 10 investors who have invested in Alessa Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
